RE:RE:RE:RE:been around a while...I would encourage you to go over the Interviews done by the CEO on some of the major news-outlets. Most can be found on YouTube now and some have been covered by Cannabis YouTube Channels as well.
The CEO indicated that there is a considerable about of sales and revenue not being reported under Canopy Growth right now due to the structure of the deals they have in the United States. I can't recall the exact numbers, and I will not guess as to their apx values, however I do believe they were mentioned.
The value of your shares in the eye of the market may be greater than you expect, once the Canopy Growth / US Business Operations Consolidation is all sorted out. If de-scheduling actually does take place by year end then this may contribute to a quicker resolution to these challenges. This may need some amount of time "post-rescheduling" however I am optimistic that by having Cannabis scheduled down to a lesser catagory then the regulations on how the businesses can operator will relax.
Regarding high-averages, I made a post yesterday regarding how I get those down using a Dollar Cost Average approach, just check my post history. I do apologize for how poorly I wrote that one but I was tired and didn't do much for proof-reading. I think the jest of the method is conveyed properly though.
All the best
Q